SALERNITANA | February 2019

Share
Facebook
Twitter
Pinterest
LinkedIn
Email
Print

By Goutham Rao, MD, FAHA
UH Chief Clinician Experience Officer

Goutham Rao, MDGoutham Rao, MD, FAHA

On behalf of Chief Academic Officer Dr. Mukesh Jain, I am pleased to provide details about two new research centers of excellence recently established at University Hospitals.

One is the Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA). The CINEMA will be led Dr. Sanjay Rajagopalan, MD, Chief, Division of Cardiovascular Medicine, Department of Medicine at University Hospitals.

The center will leverage multiple pre-existing partnerships and collaborations within and outside of the institution to create an integrated, multidisciplinary program focused on better understanding and treatment of cardiac and vascular complications of Type 2 diabetes.

We anticipate that the CINEMA’s efforts will lead to development of better methods for detecting sub-clinical vascular disease, therapeutics for treatment and technology-based approaches to improve the lives of patients with diabetes and cardiovascular complications – including implementation science and personalized medicine.

The other is the Center of Excellence for Translational Neuro-Oncology (CETNO).

The CETNO will be led by Andrew E. Sloan, MD, the Peter D. Cristal Chair of Neurosurgical Oncology, Director, Brain Tumor and Neuro-Oncology Center and senior neurosurgeon at University Hospitals.

The CETNO will focus on critical challenges in neuro-oncology, such as the paucity and lack of specificity of biomarkers along with intra-tumoral heterogeneity that limit the clinician’s ability to understand and follow responses to brain tumor treatment. The Center will bring together multiple departments and centers at UH to create a unique platform to advance the understanding and treatment of brain tumors.

Share
Facebook
Twitter
Pinterest
LinkedIn
Email
Print
Back to Top